Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 1-20 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 1 | ICEYE highstrong | Opp 9 Risk 3 | Thesis: Recent very large funding, high stated valuation, and evidence of expanding sovereign SAR demand support a durable multi-quarter scaling thesis. Why now: On June 9, 2026 ICEYE disclosed a €450 million primary Series F at valuation above €10 billion, with total round size above €1 billion including secondary, and later June context also referenced a €300 million revolving credit facility and additional sovereign satellite demand; those are recent business-state signals for a 1 year+ horizon. Evidence
Caveats: Some support is supporting article context rather than company-specific positive evidence. Several supporting demand/customer references are undated, so recency is uncertain for those claims. |
| 2 | SpaceX highstrong | Opp 9 Risk 4 | Thesis: SpaceX has the strongest evidence-set-backed long-horizon opportunity because it secured multiple large, recent government awards that deepen its role as a core military and civil space infrastructure provider, with contract scope spanning surveillance, communications backbone, and additional NASA crew missions. Why now: The timing is supported by late-May 2026 contract awards: a $2.29 billion Space Force data-network award dated May 26, 2026 and a $4.16 billion Space Force SB-AMTI award dated May 29, 2026/May 30, 2026, plus NASA's plan dated May 24, 2026 to add missions to SpaceX's commercial crew contract, all of which indicate durable backlog expansion and franchise entrenchment over a 1 year+ horizon. Evidence
Caveats: The reviewed sources' available source fields contain no direct positive or negative events for SpaceX; opportunity is inferred from high-materiality neutral facts and article summaries. Ticker mapping is noisy in the reviewed sources: SpaceX is shown with ticker TSLA, which should not be treated as validated public-company identity here. |
| 3 | Apex Space mediummedium | Opp 8 Risk 4 | Thesis: Apex has the strongest opportunity case in this screen because multiple dated June 2026 sources say it raised over $200 million at a $2.3 billion valuation specifically to scale high-rate satellite bus production for proliferated constellations, and a separate dated June 2026 article says Northrop partnered with Apex on space-based interceptors for Golden Dome. Together, these indicate fresh capital, scaling intent, and positioning with government/defense demand vectors over a 1 year+ horizon. Why now: Why now is strong because the key financing evidence is dated June 5, 2026 and the Northrop partnership article is dated June 1, 2026, making both recent within the 90-day recent evidence window and relevant to a 1 year+ scaling thesis. The June 5 financing event is later than the April 16 capacity/context article and therefore better reflects current business state. Evidence
Caveats: Most available evidence is neutral fact or supporting article context, not explicit positive events. Same-day repeated articles around the fundraise are not independent proof beyond corroboration. Some context sources are company-issued or article-level summaries, which are weaker than direct events. |
| 4 | AST SpaceMobile, Inc. highstrong | Opp 8 Risk 5 | Thesis: AST SpaceMobile has strong long-horizon opportunity because it achieved a critical regulatory milestone for a 248-satellite direct-to-device constellation and continues to show ecosystem buildout through operator partnerships and stated constellation scale targets. Why now: The key timing event is the FCC authorization dated April 21, 2026/April 22, 2026 granting authority for up to 248 satellites and direct-to-device service, a milestone that can unlock U.S. commercial and government use cases over a 1 year+ horizon. Later-dated company-site context on June 23, 2026 also says AST has nearly 60 operator partners and targets direct broadband to standard smartphones. Evidence
Caveats: Much of the evidence is company, press-release, or article-context based rather than independent hard performance metrics. The reviewed sources cites a target of 45 to 60 BlueBird satellites by end-2026 in article summary context, but this is not available as a direct structured fact here. |
| 5 | BlackSky Technology Inc. highstrong | Opp 8 Risk 4 | Thesis: BlackSky has the strongest recent opportunity evidence in the screen: a multi-year sole-source $99 million U.S. government IDIQ tied to next-generation Earth observation and space domain awareness development, plus a separate $25 million multi-year assured contract with a major international defense customer. Together these indicate current government demand, product validation, and longer-horizon backlog/ARR support. Why now: The why-now is supported by two dated recent wins inside the recent evidence window: on March 31, 2026 BlackSky said it received a multi-year sole-source $99 million U.S. government IDIQ and initial $2 million funding for advanced large-aperture payload design; on April 22, 2026 it announced a competitive $25 million multi-year assured contract with a major international defense customer and said it had four Gen-3 satellites on orbit and was rapidly deploying Gen-3 capacity while driving up backlog and annual recurring revenue. Evidence
Caveats: The $99 million figure is an IDIQ ceiling, not fully funded revenue at announcement; only an initial $2 million was specifically disclosed. Some corroboration repeats the same underlying announcement and should not be treated as independent evidence |
| 6 | Boeing highstrong | Opp 8 Risk 2 | Thesis: Boeing has the strongest opportunity evidence in this screen because the reviewed sources includes recent company-linked fact evidence that it won a $2 billion U.S. Space Force contract to build two next-generation MUOS communications satellites. The award covers design, development, production, testing, and on-orbit support for a critical military SATCOM network, with launches no earlier than 2031 and 2032 and constellation support through 2035. That is a material, durable space/defense win aligned with the 1 year+ horizon Why now: Why now is strong because the contract was reported on June 23-25, 2026, making it recent within the 90-day recent evidence window, and it represents a fresh, material U.S. defense-space award with multiyear strategic relevance Evidence
Caveats: Some corroborating rows are supporting article context and should not be overcounted as independent confirmation. Program financial benefits may phase in over a long cycle given first delivery timing in 2031. |
| 7 | Capella Space highstrong | Opp 8 Risk 4 | Thesis: Capella Space has the strongest opportunity profile in this screen because the reviewed sources includes a dated, company-specific contract fact showing it won a roughly $49 million SDA contract to build two satellites for a military communications demonstration, adding to evidence that it operates advanced SAR satellite capabilities and serves government and strategic customers. Why now: The April 8, 2026 SDA award is recent within the recent evidence window and is directly relevant to a 1 year+ horizon because it funds spacecraft design and development for a government demonstration program. Later context articles in April-June 2026 continue to depict Capella as an operating SAR platform with defense exposure. Evidence
Caveats: The positive contract evidence is classified as a neutral supporting fact in the reviewed sources, so direction is inferred from the business substance rather than explicit positive polarity labeling. Several contextual articles mention a planned acquisition or subsidiary status, but time-sensitive ownership/public-status interpretations should be treated cautiously because not all such references are direct, dated transaction-closing evidence. For example, and |
| 8 | Impulse Space mediummedium | Opp 8 Risk 4 | Thesis: Impulse Space has the strongest opportunity setup in this screen based on recent, company-linked financing evidence that it raised $500 million in Series D funding to scale production of orbital transfer vehicles, with article context also indicating expansion to support growing commercial and government demand. For a 1 year+ horizon, that capital base can support production scale-up and program execution. Why now: The catalyst is recent and dated: on June 2, 2026/June 3, 2026, Impulse Space disclosed a $500 million Series D and total capital raised above $1 billion, which is highly relevant for a 1 year+ scaling thesis. Evidence
Caveats: Some supportive items are supporting article context and should not be treated as independent confirmation if repeating the same financing announcement. Older commercial contract and government contract references in representative articles are outside the 90-day recent evidence window and therefore not primary recency support here. |
| 9 | Katalyst Space Technologies highstrong | Opp 8 Risk 6 | Thesis: Katalyst Space Technologies has a strong opportunity profile because the reviewed sources show recent evidence of both mission relevance and financing: a NASA Phase III SBIR contract to develop a rescue concept for the Neil Gehrels Swift Observatory and a later June 23, 2026 report that it raised $12 million to develop its NEXUS robotic spacecraft and expand satellite servicing. Why now: Why now is strong because the latest dated evidence on June 23, 2026 adds new capital after the May 29, 2026 NASA-related mission context, supporting a 1 year+ thesis that the company is moving from concept credibility toward funded development in on-orbit servicing. Evidence
Caveats: Part of the positive case comes from company-issued materials and supporting article context rather than independent positive evidence. The May 29, 2026 article includes a dated source date but describes an announcement text beginning 'August 11, 2025'; chronology should therefore be read carefully, with the treated as the recency marker for this retrieved item. Citation |
| 10 | Northrop Grumman Corp mediumstrong | Opp 8 Risk 3 | Thesis: Northrop Grumman has the strongest reviewed sources-supported opportunity profile in this screen due to multiple recent space-defense catalysts: inclusion in the April 8, 2026 Andromeda RG-XX awards, a June 1, 2026 partnership with Apex on Golden Dome space-based interceptors, and a June 22, 2026 $398M Space Force contract for the Enhanced Protected Tactical SATCOM Prototype. Together these support a durable 1 year+ defense-space demand thesis. Why now: The setup is current and cumulative: April 8, 2026 Andromeda participation, June 1, 2026 Golden Dome interceptor partnership, and June 22, 2026 award of a $398M protected satcom contract all fall within the 90-day recent evidence window and point to sustained momentum. Evidence
Caveats: The reviewed sources does not provide direct business impact breakdowns beyond the $398M contract article. Some support is supporting article context rather than dated events. |
| 11 | Observable Space mediummedium | Opp 8 Risk 4 | Thesis: Observable Space has the strongest positive setup in this screen because the reviewed sources contain dated evidence that it raised a $90 million Series A and secured a $94 million U.S. Space Force optical-systems contract, supporting capital availability, customer validation, and potential multi-quarter execution runway. Why now: The timing is favorable because on May 28, 2026 the company was reported to have both closed a $90 million Series A and announced a $94 million U.S. Space Force award, with additional follow-on reporting on June 9, 2026 indicating the contract landed just weeks after the raise, suggesting a recent step-change in funding and government traction for a 1 year+ horizon Evidence
Caveats: Positive direction is inferred from neutral facts plus article summaries; the reviewed sources does not provide explicit positive events. Same-article repeated rows are not independent confirmation. Supporting web-search evidence is context and should be treated below directly cited company evidence. |
| 12 | PLD Space highstrong | Opp 8 Risk 4 | Thesis: PLD Space has recent financing, strategic customer/investor validation, infrastructure investment, and a first commercial launch contract, all of which support a durable launch-scaling thesis over the next year-plus. Why now: The reviewed sources show a sequence of material developments: €180 million Series C on March 4, 2026, €30 million EIB venture debt signed April 7, 2026 and reported May 6, 2026/04-07, first commercial contract reported May 21, 2026, and €35 million Kourou launch-complex investment on June 1, 2026 while MIURA 5 remained on track for a late-2026 first test flight. That is strong state-change evidence for a 1 year+ horizon. Evidence
Caveats: Risk evidence is partly inferred from dependency on future launch milestones rather than a disclosed adverse event. Most support is supporting article context, though the chronology is consistent and material. |
| 13 | Quantum Space mediummedium | Opp 8 Risk 5 | Thesis: Quantum Space has the clearest evidence-backed opportunity profile in this screen: within the recent evidence window it announced a SPAC merger expected to bring substantial capital and public-market access, and later won a Pentagon-funded orbital refueling spacecraft contract built on its Ranger platform. Those developments support a durable 1 year+ thesis around funding access, national-security positioning, and product relevance in on-orbit logistics. Why now: The evidence is recent and sequenced: on June 8, 2026 Quantum Space announced its planned SPAC merger and expected Nasdaq listing under QSPC Evidence
Caveats: Most available evidence is external overlay context rather than first-party positive or negative events. Same-theme repetition across June articles is not independent confirmation. Ticker QSPC is prospective after the expected SPAC close per June 8, 2026 evidence, not confirmed as already trading under that symbol |
| 14 | True Anomaly highstrong | Opp 8 Risk 4 | Thesis: True Anomaly has the strongest opportunity profile in this screen because the reviewed sources contain dated, company-linked evidence that it raised $650 million in Series D financing at a $2.2 billion valuation on April 28, 2026 and was selected by the U.S. Space Force for the Space-Based Interceptor program on May 4, 2026. For a 1 year+ horizon, that combination of fresh capital plus program participation supports scaling, product development, and defense-space positioning. Why now: The recent sequence matters: on April 28, 2026, True Anomaly announced a $650 million Series D at a $2.2 billion valuation, also. Then on May 4, 2026, a dated article said the company was selected by the U.S. Space Force Space Systems Command for the Space-Based Interceptor program. That capital-plus-program sequence is directly relevant to a long-horizon growth thesis. Evidence
Caveats: Most evidence is external overlay context/facts rather than primary data source direct events. Several sources repeat the same April 28 financing story and are not independent confirmation of different events. The company-site article is undated, so recency-sensitive claims from it should be treated cautiously. |
| 15 | Anduril Industries mediummedium | Opp 7 Risk 5 | Thesis: Anduril has a credible 1 year+ opportunity setup from recent participation in major U.S. defense-space programs and fresh financing context. Recent article context says Anduril was among companies awarded Space Force Andromeda contracts for the RG-XX satellite effort on April 8, 2026, and a later article says Anduril raised a $5B Series H round published June 19, 2026, supporting capital availability for scaling in defense-space programs. Why now: The timing is supported by recent 2026 article context around Space Force Andromeda participation and the June 19, 2026 financing context, which together suggest active momentum over the last quarter. Evidence
Caveats: Most evidence is weak context-only article evidence, not direct positive events in the available ranking rows. |
| 16 | Astroscale mediummedium | Opp 7 Risk 4 | Thesis: Astroscale has the clearest 1 year+ opportunity setup in this screen: within the recent evidence window article context shows recent funding support, strategic growth financing for medium-to-long-term expansion, and a shift from demos toward repeatable commercial missions, including defense-related servicing and a 2027 inspection mission pipeline. Why now: Recency is the main reason: on June 22, 2026 SpaceNews said Astroscale was 'working to transition from technology demonstrations to a regular series of missions, bolstered by a recent capital infusion' and saw 'repeatable business opportunities' particularly among defense customers. On May 19, 2026 financing materials said the company would raise 30.6 billion yen to secure medium-to-long-term growth funding 'in anticipation of transitioning to a phase of continuous order acquisition'. On April 6, 2026 Astroscale revealed its ISSA-J1 mission scheduled for launch in 2027. Evidence
Caveats: Most within the recent evidence window evidence is supporting article context, not structured company-specific events; reviewed sources warns supporting article context is weaker than direct event/fact evidence. Same-article repeated weak-context rows are not independent confirmation. Older 2023 and 2025 articles exist in representative articles but fall outside the 90-day recent evidence window for ranking use. |
| 17 | ClearSpace mediummedium | Opp 7 Risk 3 | Thesis: Best opportunity profile in this screen based on multiple dated article-context items showing the company remains active in in-orbit servicing/debris removal, has financing support, is ramping toward ClearSpace-1, and is expanding into defense-adjacent partnership activity. For a 1 year+ horizon, that combination supports a credible strategic growth and market-positioning thesis. Why now: Why now is supported by recent dated context: on June 24, 2026, SpaceNews reported ClearSpace signed an MOU with Shield Space to develop sovereign space defense capabilities for the UK and allies, indicating adjacent market expansion. On May 19, 2026, the company site said it had finalized a EUR 26.7 million Series A and was ramping operations ahead of ClearSpace-1 scheduled to launch in 2026. These dated items fit a 1 year+ horizon because they point to ongoing commercialization and mission preparation. Evidence
Caveats: Most evidence is supporting article context, not direct positive events. The financing article published on May 19, 2026 references January 19, 2023 for the Series A round, so funding recency versus page recency should not be conflated. |
| 18 | Cowboy Space mediummedium | Opp 7 Risk 4 | Thesis: Cowboy Space has the strongest positive evidence in this screen: a large Series B financing at a substantial valuation, explicit plans to build vertically integrated rockets plus orbital data-center infrastructure, and stated hiring/buildout activity. That combination supports a durable 1 year+ strategic opportunity thesis. Why now: Multiple dated articles on May 11, 2026 report Cowboy Space raised $275 million in Series B financing at a $2 billion valuation to build rockets with orbital data-center upper stages, and a TechCrunch article says the company is standing up its own rocket program with a first launch expected before end-2028 Evidence
Caveats: The reviewed sources contain no explicit negative event evidence; risk is inferred from execution complexity and long timeline, not from adverse events. Several supporting rows repeat the same May 11, 2026 financing story and are not independent confirmation. Some supporting article context is undated and should be treated cautiously for recency. |
| 19 | Dawn Aerospace mediummedium | Opp 7 Risk 3 | Thesis: Dawn Aerospace has the strongest opportunity evidence in this screen because a recent dated company article says it closed a $25 million Series B at a $195 million post-money valuation to accelerate global expansion of reusable space transportation. The funding is directly tied to rollout, commercial scaling in the US and Europe, and support for an expanding international customer base, which fits a 1 year+ horizon. Why now: The key catalyst is recent and explicit: on June 16, 2026 the company announced the Series B close and said the proceeds will finance global rollout and scaling of commercial and operational teams in the US and Europe. Evidence
Caveats: Evidence comes from a company-published article, so it is not fully independent. No direct structured positive event row is provided beyond supporting article context. |
| 20 | Eutelsat Communications SA mediummedium | Opp 7 Risk 4 | Thesis: Eutelsat has a strong long-horizon opportunity case from the reviewed sources' membership rationale stating it is supervising a 264-satellite IRIS2 element and won a €350M French defense satellite contract with sovereign LEO capacity. That combines infrastructure scale with government-backed demand. Why now: The reviewed sources' membership rationale cites current program/contract relevance through support articles 2026-04, and: but were not provided in the payload, limiting precise timing narration. Evidence
Caveats: The reviewed sources does not provide for the membership-support article IDs. Opportunity score is tempered by the absence of kept direct evidence in the ranking payload. |
Risk view
Showing rows 1-20 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 1 | Blue Origin mediummedium | Opp 6 Risk 7 | Thesis: Execution risk is elevated because the same recent evidence set documents a New Glenn launchpad explosion on May 28, 2026, creating material uncertainty around launch reliability and schedule even though government customers reaffirmed support. Why now: The setup is active and recent: on May 30, 2026 SpaceNews reported Blue Origin received an NSSL task order hours before a New Glenn explosion, while on May 27, 2026 GeekWire reported New Glenn was preparing to return to service for an Amazon Leo mission after its first launch failure; on May 26, 2026 Investing.com summarized a NASA moon-base contract with launch no earlier than fall 2026 Evidence
Caveats: Positive evidence is mostly supporting article context rather than direct events. One external article is undated and is not relied on for recency proof. Government support after the anomaly partially offsets, but does not erase, execution risk. |
| 2 | Katalyst Space Technologies highstrong | Opp 8 Risk 6 | Thesis: Risk is also elevated because the mission profile is technically ambitious and schedule-sensitive: the rescue concept is framed as potentially the first time a commercial robotic spacecraft docks with an unprepared government satellite, and the telescope is described as at risk of deorbit by late 2026, implying high execution stakes. Why now: Why now is strong because the latest dated evidence on June 23, 2026 adds new capital after the May 29, 2026 NASA-related mission context, supporting a 1 year+ thesis that the company is moving from concept credibility toward funded development in on-orbit servicing. Evidence
Caveats: Part of the positive case comes from company-issued materials and supporting article context rather than independent positive evidence. The May 29, 2026 article includes a dated source date but describes an announcement text beginning 'August 11, 2025'; chronology should therefore be read carefully, with the treated as the recency marker for this retrieved item. Citation |
| 3 | Anduril Industries mediummedium | Opp 7 Risk 5 | Thesis: Risk remains elevated because the reviewed sources' evidence is mostly supporting article context rather than company-specific positive evidence, and program participation does not confirm revenue realization, production conversion, or margin outcomes. The capital raise also implies a company still in heavy scale-up mode rather than de-risked execution. Why now: The timing is supported by recent 2026 article context around Space Force Andromeda participation and the June 19, 2026 financing context, which together suggest active momentum over the last quarter. Evidence
Caveats: Most evidence is weak context-only article evidence, not direct positive events in the available ranking rows. |
| 4 | AST SpaceMobile, Inc. highstrong | Opp 8 Risk 5 | Thesis: Risk remains elevated because the thesis still depends on large-scale deployment and commercialization execution; the reviewed sources show authorization and partnerships, but limited direct proof of broad revenue conversion or completed network rollout inside the recent evidence window. Why now: The key timing event is the FCC authorization dated April 21, 2026/April 22, 2026 granting authority for up to 248 satellites and direct-to-device service, a milestone that can unlock U.S. commercial and government use cases over a 1 year+ horizon. Later-dated company-site context on June 23, 2026 also says AST has nearly 60 operator partners and targets direct broadband to standard smartphones. Evidence
Caveats: Much of the evidence is company, press-release, or article-context based rather than independent hard performance metrics. The reviewed sources cites a target of 45 to 60 BlueBird satellites by end-2026 in article summary context, but this is not available as a direct structured fact here. |
| 5 | Atomic-6 lowweak | Opp 4 Risk 5 | Thesis: Risk is moderate because none of the underlying article summaries or are provided in the visible evidence section, so the apparent positives cannot be independently grounded from the reviewed sources output beyond the rationale text. Why now: The reviewed sources rationale cites article and says Atomic-6 launched an orbital data center service and has DoD and U.S. Space Force contracts, but no representative article or is provided in the visible reviewed sources, so timing confidence is limited. Caveats: No direct evidence or article are available in the reviewed sources body. Opportunity thesis relies on membership rationale rather than citable article summary. Because the underlying evidence is not exposed, conviction must stay low. |
| 6 | Intuitive Machines, Inc. mediummedium | Opp 6 Risk 5 | Thesis: Risk is also moderate because the evidence is lighter than for top-ranked names and the key contract appears to be an IDIQ selection/competition vehicle rather than a clearly quantified standalone revenue award in the reviewed sources. Why now: The timing case comes from May 12, 2026 reporting that Intuitive Machines was selected for the Space Force Andromeda IDIQ to develop space surveillance capabilities through 2030 and beyond, described as the company's first major selection following the Lanteris Space acquisition. Evidence
Caveats: The reviewed sources provide supporting article context but no direct structured fact with quantified contract value specific to Intuitive Machines. No direct adverse evidence is available; risk is based on competitive award structure and evidence limitations. Long-horizon upside depends on conversion from selection status into meaningful programs. |
| 7 | Momentus mediummedium | Opp 7 Risk 5 | Thesis: Risk remains elevated because the evidence set emphasizes announcements and pipeline/contract positioning rather than broad proof of scaled recurring commercial adoption; some supportive contract context, including SHIELD selection, is older than the recent evidence window and should not be over-weighted for recency. Why now: Why-now is supported by recent mission and contract evidence within the recent evidence window: on March 30, 2026 Momentus announced the successful launch of Vigoride 7 and called it its most advanced on-orbit demonstration campaign to date; on June 17, 2026 it announced a new commercial contract with LASP to host and operate the OWLS mission on Vigoride-9, expanding its commercial revenue portfolio. Evidence
Caveats: The SHIELD contract-vehicle selection is dated December 10, 2025 and outside the 90-day recent evidence window, so it is useful background but not a recency catalyst here. Some weak context rows repeat the same article-level claims and are not independent confirmation. |
| 8 | Momentus Inc lowweak | Opp 4 Risk 5 | Thesis: Momentus receives the highest risk score in the thin-evidence group because the reviewed sources references a commercial contract but provides no current available corroboration, leaving substantial uncertainty around execution, financing durability, and contract conversion. This is still an evidence-gap risk, not a confirmed adverse-event thesis, because no direct negative evidence is available (: and: unavailable in reviewed sources). Why now: Why now is medium because an orbital services contract can matter over a 1 year+ horizon, but the reviewed sources' post-recent evidence window evidentiary absence prevents stronger timing confidence. Caveats: No direct evidence remained after the recent evidence filter. |
| 9 | Orbex mediumweak | Opp 1 Risk 5 | Thesis: Risk is moderate because the only described usable context says the company was looking to secure its future, while all dated evidence shown is outside the allowed recent evidence window, leaving the current business state uncertain. Why now: The only surfaced article is dated February 17, 2026, outside the reviewed sources cutoff date of March 29, 2026, and the evidence recent evidence review says both rows were dropped; the article summary said Orbex released new photographs of its microlauncher Prime 'as the company looks to secure a future'. Because this is outside recent evidence window, recency support is absent. Evidence
Caveats: Primary surfaced evidence is outside recent evidence window and should not be treated as current proof. No in-recent evidence window direct positive or negative evidence is available. |
| 10 | Orbital Inc. mediummedium | Opp 6 Risk 5 | Thesis: Risk is moderate because the reviewed sources provide only supporting article context and no direct evidence of contracts, deployment milestones, customer traction, or technical validation beyond the funding/context claim. Why now: The usable evidence is recent within the 90-day recent evidence window: an April 14, 2026 article said Orbital got funded by Andreessen Horowitz to verify its space-based data center concept, which is relevant to a 1 year+ horizon because financing can support technology proof and strategic positioning Evidence
Caveats: Evidence is supporting article context/weak context rather than direct positive events. No reviewed sources evidence of customers, revenue, launch schedule, or technical milestone completion. Same article appears in multiple weak-context rows and should not be treated as independent confirmation. |
| 11 | Quantum Space mediummedium | Opp 8 Risk 5 | Thesis: The company still carries meaningful execution and transaction risk because the SPAC deal is only expected to close in the fourth quarter rather than already complete, contract value was undisclosed, and key program delivery is pushed out to 2028, leaving room for financing, closing, and execution slippage. Why now: The evidence is recent and sequenced: on June 8, 2026 Quantum Space announced its planned SPAC merger and expected Nasdaq listing under QSPC Evidence
Caveats: Most available evidence is external overlay context rather than first-party positive or negative events. Same-theme repetition across June articles is not independent confirmation. Ticker QSPC is prospective after the expected SPAC close per June 8, 2026 evidence, not confirmed as already trading under that symbol |
| 12 | Sateliot mediummedium | Opp 7 Risk 5 | Thesis: Risk remains material because later evidence indicates the Series C is being sought rather than fully closed and that Sateliot is still seeking a lead investor, with up to 50% public co-financing hoped to match private investment. That means financing completion and constellation deployment remain execution-sensitive. Why now: The sequence matters: the company launched the Series C on April 8, 2026/April 13, 2026, then later reporting on May 21, 2026 noted a first commercial launch contract, and June 24, 2026 reporting still described the round as seeking capital and a lead investor. That mix creates both opportunity and financing risk over a 1 year+ horizon. Evidence
Caveats: The reviewed sources does not provide a direct positive event row for the first commercial contract; that support is supporting article context and weaker than a structured company event row. Later dated coverage indicates financing is still being sought, which partially offsets the opportunity thesis. Undated context items exist in the reviewed sources but are not used for recency-sensitive judgments. |
| 13 | Spark Space mediummedium | Opp 5 Risk 5 | Thesis: Risk is equally meaningful because the evidence is undated supporting article context, so recency is uncertain and there is no direct evidence of launch contracts, orbital milestones, or sustained financing beyond the article summary. Why now: The reviewed sources retains undated evidence indicating Spark Space tested its engine and raised funds for an electric-pump rocket, but the article has no publication timestamp, so recency-sensitive claims should be treated cautiously. Evidence
Caveats: Article is undated, so business-state recency is uncertain. Evidence is supporting article context, not direct dated event/facts. Same article appears twice in weak-context rows and is not independent confirmation. |
| 14 | Turion Space mediummedium | Opp 7 Risk 5 | Thesis: Risk remains meaningful because the evidence still describes an early-stage company scaling from a small launched base into a persistent constellation and potentially adjacent on-orbit services, which implies execution and capital deployment risk; however, the reviewed sources contain no direct adverse event evidence. Why now: The key timing driver is the dated financing round on April 15, 2026, which the reviewed sources say positions the company to scale beyond single-mission spacecraft toward a persistent SDA constellation, a development relevant over a 1 year+ horizon. Evidence
Caveats: The reviewed sources have no direct positive or negative dated events; the case relies on supporting article context rather than stronger internal company-specific events. The company website context on May 23, 2026 is weaker than independent company-specific event evidence and should not be overweighted. Citation |
| 15 | Volta Space Technologies lowweak | Opp 4 Risk 5 | Thesis: Risk is moderate to elevated because the cited milestone is far out, execution risk is likely high, and the reviewed sources exposes no direct article summary or to confirm near-term de-risking. Why now: The rationale cites article and says the company has a 2028 demonstration planned with payload booked on Blue Ghost Mission 2, which is relevant to a 1 year+ strategic horizon but weak for immediate evidence-based ranking because no article body or is visible. Caveats: No visible representative article, quote, or in the reviewed sources body. The main cited demonstration is scheduled for 2028, so commercial payoff may sit beyond the stated 1 year+ ranking horizon. The Firefly payload linkage cannot be used as counterparty propagation evidence beyond the explicit rationale. |
| 16 | Albedo lowweak | Opp 4 Risk 4 | Thesis: Risk is also meaningful because this evidence is supporting article context only, not direct event/fact evidence in the reviewed sources' stronger fields, and the article describes Albedo as a former Earth-observation startup now focused on satellite manufacturing, implying strategic transition/execution uncertainty Why now: Why now is stronger than for most names because the reviewed sources includes a dated representative article with April 9, 2026, stating that on April 9 Albedo announced plans for its second spacecraft and a 2027 launch for its second VLEO mission Evidence
Caveats: The reviewed sources marks this as weak context only / supporting article context, not strong direct event evidence. Same article appears in multiple weak-context rows and should not be treated as independent confirmation. |
| 17 | Apex Space mediummedium | Opp 8 Risk 4 | Thesis: Risk is moderate, not because of explicit adverse evidence, but because the strongest structured support is neutral fact/context rather than explicit positive events in the reviewed sources. The evidence leans heavily on company/external article context and financing narratives, so execution risk around scaling manufacturing and converting strategic positioning into durable contracts remains an offset. Why now: Why now is strong because the key financing evidence is dated June 5, 2026 and the Northrop partnership article is dated June 1, 2026, making both recent within the 90-day recent evidence window and relevant to a 1 year+ scaling thesis. The June 5 financing event is later than the April 16 capacity/context article and therefore better reflects current business state. Evidence
Caveats: Most available evidence is neutral fact or supporting article context, not explicit positive events. Same-day repeated articles around the fundraise are not independent proof beyond corroboration. Some context sources are company-issued or article-level summaries, which are weaker than direct events. |
| 18 | Astrobase Space Technologies mediummedium | Opp 6 Risk 4 | Thesis: Risk remains material because the visible evidence is supporting article context around funding and ambition rather than proof of technical milestone completion, customer adoption, or flight success. Deep-tech engine development inherently depends on execution, but the reviewed sources does not document adverse events. Why now: The funding article is recent, with published June 12, 2026, and specifically notes this as IN-SPACe's first investment in Indian startups under the TAF scheme. That timing matters for a 1 year+ horizon because it may enable development progress over coming quarters. Evidence
Caveats: Visible evidence is only one external article summary despite the membership rationale referencing multiple structured support articles. No technical test results or customer contracts are provided in the exposed evidence. |
| 19 | Astroscale mediummedium | Opp 7 Risk 4 | Thesis: The reviewed sources also indicates Astroscale is still transitioning from technology demonstrations into repeatable commercial work, and its May 2026 financing cites an uncertain market environment, so scaling and capital-market dependence remain meaningful risks. Why now: Recency is the main reason: on June 22, 2026 SpaceNews said Astroscale was 'working to transition from technology demonstrations to a regular series of missions, bolstered by a recent capital infusion' and saw 'repeatable business opportunities' particularly among defense customers. On May 19, 2026 financing materials said the company would raise 30.6 billion yen to secure medium-to-long-term growth funding 'in anticipation of transitioning to a phase of continuous order acquisition'. On April 6, 2026 Astroscale revealed its ISSA-J1 mission scheduled for launch in 2027. Evidence
Caveats: Most within the recent evidence window evidence is supporting article context, not structured company-specific events; reviewed sources warns supporting article context is weaker than direct event/fact evidence. Same-article repeated weak-context rows are not independent confirmation. Older 2023 and 2025 articles exist in representative articles but fall outside the 90-day recent evidence window for ranking use. |
| 20 | BlackSky Technology Inc. highstrong | Opp 8 Risk 4 | Thesis: Risk is still moderate because the $99 million item is an IDIQ ceiling with only initial funding disclosed, and much of the reviewed sources support is article-context level rather than dated events; execution on next-generation payload design and constellation roadmap still matters. Why now: The why-now is supported by two dated recent wins inside the recent evidence window: on March 31, 2026 BlackSky said it received a multi-year sole-source $99 million U.S. government IDIQ and initial $2 million funding for advanced large-aperture payload design; on April 22, 2026 it announced a competitive $25 million multi-year assured contract with a major international defense customer and said it had four Gen-3 satellites on orbit and was rapidly deploying Gen-3 capacity while driving up backlog and annual recurring revenue. Evidence
Caveats: The $99 million figure is an IDIQ ceiling, not fully funded revenue at announcement; only an initial $2 million was specifically disclosed. Some corroboration repeats the same underlying announcement and should not be treated as independent evidence |